Description

Pyrazinecarboxamide, n-Cyclopentyl-n-[(9-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci) is a sophisticated heterocyclic organic compound featuring a unique fused quinoline-tetrazole core structure. This molecule matters as a high-value pharmaceutical intermediate or research chemical with significant potential in medicinal chemistry for the development of novel bioactive agents. It is primarily needed by pharmaceutical R&D laboratories and fine chemical synthesis facilities engaged in creating new therapeutic candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Chemical Biology Probe: Serves as a specialized tool compound for investigating biological processes and protein interactions.
• Fine Chemical Synthesis: Intermediate for the production of more complex, high-value specialty chemicals with specific functionalities.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis projects and novel heterocycle development.

Basic Information

Product Name	Pyrazinecarboxamide, n-Cyclopentyl-n-[(9-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci)
CAS No.	603949-47-9
Molecular Formula	C20H21N7O
Molecular Weight	375.43 g/mol
Synonyms	N-Cyclopentyl-N-[(9-methyltetrazolo[1,5-a]quinolin-4-yl)methyl]pyrazine-2-carboxamide; 2-Pyrazinecarboxamide, N-cyclopentyl-N-[(9-methyltetrazolo[1,5-a]quinolin-4-yl)methyl]-; CAS 603949-47-9; 603949-47-9; N-Cyclopentyl-N-((9-methyltetrazolo[1,5-a]quinolin-4-yl)methyl)pyrazine-2-carboxamide; Pyrazine-2-carboxylic acid N-cyclopentyl-N-[(9-methyl-[1,2,4]triazolo[1,5-a]quinolin-4-yl)methyl]amide (related structure); Tetrazoloquinoline pyrazinecarboxamide derivative.
EINECS	Contact for details

Quality Control

Our high-purity batch of Pyrazinecarboxamide, n-Cyclopentyl-n-[(9-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci) is produced under strict quality management systems. Each lot undergoes comprehensive analytical characterization including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis to ensure it meets the exacting standards required for research and development. Certificates of Analysis (COA) with full analytical data are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound may be hygroscopic; therefore, containers should be kept tightly sealed in a dry environment to prevent moisture uptake. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Retention time matches reference standard
Identification (NMR)	Spectrum consistent with structure
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.